Your browser doesn't support javascript.
loading
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
Gilliland, Thomas C; Liu, Yuxi; Mohebi, Reza; Miksenas, Hannah; Haidermota, Sara; Wong, Megan; Hu, Xingdi; Cristino, Joaquim Rosado; Browne, Auris; Plutzky, Jorge; Tsimikas, Sotirios; Januzzi, James L; Natarajan, Pradeep.
Affiliation
  • Gilliland TC; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massach
  • Liu Y; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mohebi R; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Miksenas H; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Haidermota S; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Wong M; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Hu X; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Cristino JR; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Browne A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Plutzky J; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Tsimikas S; Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, California, USA.
  • Januzzi JL; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA.
  • Natarajan P; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massach
J Am Coll Cardiol ; 81(18): 1780-1792, 2023 05 09.
Article in En | MEDLINE | ID: mdl-37137588
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cardiovascular Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cardiovascular Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2023 Document type: Article Country of publication: United States